Cyclin E–Associated Kinase Activity Predicts Response to Platinum-Based Chemotherapy | Citedby Results | Clinical Cancer Research | American Association for Cancer Research

Skip to Main Content

Skip Nav Destination

Cyclin E–Associated Kinase Activity Predicts Response to Platinum-Based Chemotherapy

Clin Cancer Res (2007) 13 (16): 4800–4806.

This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.

Homologous Recombination Deficiency and Cyclin E1 Amplification Are Correlated with Immune Cell Infiltration and Survival in High-Grade Serous Ovarian Cancer

Lilian van Wagensveld
Juliette O. A. M. van Baal
Maite Timmermans
Duco Gaillard
Lauri Borghuis
Seth B. Coffelt
Efraim H. Rosenberg
Christianne A. R. Lok
Hans W. Nijman
Loes F. S. Kooreman
Joyce Sanders
Marco de Bruijn
Lodewyk F. A. Wessels
Rianne van der Wiel
Christian Rausch
Annegien Broeks
Roy F. P. M. Kruitwagen
Maaike A. van der Aa
Gabe S. Sonke
Philip C. Schouten
Koen K. Van de Vijver
Hugo M. Horlings

Cancers (2022) 14 (23): 5965.

Cisplatin exposure causes c-Myc-dependent resistance to CDK4/6 inhibition in HPV-negative head and neck squamous cell carcinoma

Anthony M. Robinson
Richa Rathore
Nathan J. Redlich
Douglas R. Adkins
Todd VanArsdale
Brian A. Van Tine
Loren S. Michel

Cell Death & Disease (2019) 10 (11)

PKCiota promotes ovarian tumor progression through deregulation of cyclin E

A Nanos-Webb
T Bui
C Karakas
D Zhang
J P W Carey
G B Mills
K K Hunt
K Keyomarsi

Oncogene (2016) 35 (19): 2428.

Cyclin E as a potential therapeutic target in high grade serous ovarian cancer

J. Kanska
M. Zakhour
B. Taylor-Harding
B.Y. Karlan
W.R. Wiedemeyer

Gynecologic Oncology (2016) 143 (1): 152.

Increased radiosensitivity of HPV-positive head and neck cancer cell lines due to cell cycle dysregulation and induction of apoptosis

Andrea Arenz
Frank Ziemann
Christina Mayer
Andrea Wittig
Kirstin Dreffke
Stefanie Preising
Steffen Wagner
Jens-Peter Klussmann
Rita Engenhart-Cabillic
Claus Wittekindt

Strahlentherapie und Onkologie (2014) 190 (9): 839.

Cyclin-dependent kinase-specific activity predicts the prognosis of stage I and stage II non-small cell lung cancer

Hiroshi Kubo
Takashi Suzuki
Tomoko Matsushima
Hideki Ishihara
Kazuya Uchino
Satoshi Suzuki
Sachiyo Tada
Masahiro Yoshimura
Takashi Kondo

BMC Cancer (2014) 14 (1)

Limited prognostic value of tissue protein expression levels of cyclinEinDanish ovarian cancer patients: from theDanish ‘MALOVA’ ovarian cancer study

Mel C. Heeran
Claus K. Høgdall
Susanne K. Kjaer
Lise Christensen
Jan Blaakaer
Ib Jarle Christensen
Estrid V. S. Hogdall

APMIS (2012) 120 (10): 846.

Implementing an online tool for genome-wide validation of survival-associated biomarkers in ovarian-cancer using microarray data from 1287 patients

Balázs Győrffy
András Lánczky
Zoltán Szállási

Endocrine-Related Cancer (2012) 19 (2): 197.

Predictive and Prognostic Protein Biomarkers in Epithelial Ovarian Cancer: Recommendation for Future Studies

Cécile Le Page
David G. Huntsman
Diane M. Provencher
Anne-Marie Mes-Masson

Cancers (2010) 2 (2): 913.

Cyclin A2 confers cisplatin resistance to endometrial carcinoma cells via up‐regulation of an Akt‐binding protein, periplakin

Akihisa Suzuki
Akiko Horiuchi
Takashi Ashida
Tsutomu Miyamoto
Hiroyasu Kashima
Toshio Nikaido
Ikuo Konishi
Tanri Shiozawa

Journal of Cellular and Molecular Medicine (2010) 14 (9): 2305.

Serum and tissue biomarkers as predictive and prognostic variables in epithelial ovarian cancer

Angiolo Gadducci
Stefania Cosio
Roberta Tana
Andrea Riccardo Genazzani

Critical Reviews in Oncology/Hematology (2009) 69 (1): 12.